GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)

Starting soon · Not applicable

Conditions studied: Pulmonary Hypertension (Diagnosis), Pre-operative Assessment, Postoperative Complications (Cardiopulmonary), Treatment Outcomes

In brief

This study is a prospective, open-label, randomized controlled trial designed to evaluate a new artificial intelligence (AI) tool for heart monitoring. Researchers will use an AI-enabled electrocardiography (ECG) system to screen patients before they undergo surgery. The main goal is to determine if this AI system can accurately detect pulmonary hypertension and related heart diseases in the preoperative setting. The study is being conducted at Taipei Veterans General Hospital.

Key facts

Study ID

NCT07344207

Run by

Taipei Veterans General Hospital, Taiwan

People needed

1380

Starts

2026-01-05

Expected to finish

2027-01-05

Last updated by the study team

2026-01-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age between 18 and 80 years.
• Patients scheduled for non-cardiac surgery under general anesthesia.
• Patients who have a scheduled standard preoperative electrocardiogram (ECG).
• Patients capable of understanding the study and willing to provide medical records for research purposes, and who have signed the informed consent form.

You may not qualify if…

• Patients scheduled for emergency surgery.
• Patients who explicitly refuse to participate or withdraw consent.
• Patients with specific comorbidities that interfere with ECG interpretation or data collection (e.g., implanted pacemakers).

Where it is running

• Taipei Veterans General Hospital — Taipei, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.